GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Cash Receipts from Fees and Commissions

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Cash Receipts from Fees and Commissions


View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


Hunan Er-Kang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.
Executives
Shuai Fang Wen Director
Wang Jun Wen Independent director
Zuo Tian Fang Independent director
Qi Yang Supervisors
Li Yi Guo Supervisors
Chen Wen Xian Supervisors
Wang Xiang Feng Directors, executives
Liu Ai Jun Directors, executives
Luo Lang Directors, executives
Fan Yi Securities Affairs Representative
Yang Hai Ming Directors, executives
Shuai You Wen Director
Shuai Rui Wen Director
Gao Zhen Ya Executives
Cao Zai Yun Director